The odds ratio for exposure to L-dopa in the IPD patients with PN was 12.4 (95% confidence interval, 1.4–109.1). There were no differences between the groups in the use of other PD drugs ...

Department of Chemistry, Chungnam National University, Daejeon 34134, Republic of Korea ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

L-dopa remains the most powerful antiparkinsonian agent, but a minority of treated patients develop disabling motor response complications. Alternatives to L-dopa for initial treatment of ...

NLX-101 (F15599) is under development for the treatment of Rett syndrome and depression. The drug candidate is administered by oral route. The drug candidate is a new chemical entity (NCE). The drug ...

Mavoglurant is under development for the treatment of cocaine use disorder, alcohol use disorder and for language learning in young children with fragile X syndrome (FXS). The drug candidate is ...

Peroxynitrite induces cell death, and can influence signal-transduction processes, mitochondrial function and signalling of apoptosis. The formation and reactions of peroxynitrite play a ...

It is cleared for both children and adults with AADC (aromatic L-amino acid decarboxylase ... and replaces the human dopa decarboxylase (DDC) gene that is mutated in the disease, allowing dopamine ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-09-2024, the company has a total of 137.50 Crore shares outstanding.L&T Share Price Today is Rs. 3659.90 as on 03 Jan, 2025, 03:59 PM ...